International Journal of Clinical Case Reports 2024, Vol.14, No.5, 242-252 http://medscipublisher.com/index.php/ijccr 251 Gameiro S., Salnikov M., Zeng P., Barrett J., Nichols A., and Mymryk J., 2023, HPV16 intratypic variants in head and neck cancers: a north american perspective, Viruses, 15(12): 2411. https://doi.org/10.3390/v15122411 PMID: 38140652 PMCID: PMC10747106 Gašperov N.M., Sabol I., Planinić P., Grubišić G., Fistonić I., Ćorušić A., and Grce M., 2015, Methylated host cell gene promoters and human papillomavirus type 16 and 18 predicting cervical lesions and cancer, PLoS ONE, 10(6): e0129452. https://doi.org/10.1371/journal.pone.0129452 PMID: 26057381 PMCID: PMC4461273 Guo S., Gu D.N., and Chen X., 2024, Development and influencing factors of female cancers, Cancer Genetics and Epigenetics, 12(1): 27-36. https://doi.org/10.5376/cge.2024.12.0004 Jeannot E., Latouche A., Bonneau C., Calméjane M.A., Beaufort C., Ruigrok-Ritstier K., and Scholl S., 2021, Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer, Clinical Cancer Research, 27(21): 5869-5877. https://doi.org/10.1158/1078-0432.CCR-21-0625 PMID: 34210686 PMCID: PMC9401545 Jendoubi-Ferchichi M., Satouri L., Ghoul F., Malek-Mellouli M., Derbel A.M., Makni M., Reziga H., Baba A., Zili M., Segondy M., and Khélifa R., 2018, Phylogeny and classification of human papillomavirus (HPV)16 and HPV18 variants based on E6 and L1 genes in Tunisian women with cervical lesions, Asian Pacific Journal of Cancer Prevention, 19(12): 3361-3366. https://doi.org/10.31557/APJCP.2018.19.12.3361 PMID: 30583341 PMCID: PMC6428538 Kahla S., Hammami S., Kochbati L., Chanoufi M.B., and Oueslati R., 2018, HPV16 E2 variants correlated with radiotherapy treatment and biological significance in cervical cell carcinoma, Infection, Genetics and Evolution, 65: 238-243. https://doi.org/10.1016/j.meegid.2018.08.001 Kuno I., Takayanagi D., Asami Y., Murakami N., Matsuda M., Shimada Y., Hirose S., Kato M.K., Komatsu M., Hamamoto R., Okuma K., Kohno T., Itami J., Yoshida H., Shiraishi K., and Kato T., 2021, TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer, Scientific Reports, 11(1): 1-10. https://doi.org/10.1038/s41598-021-98527-2 PMID: 34584128 PMCID: PMC8478905 Lagström S., Løvestad A.H., Umu S., Ambur O., Nygård M., Rounge T., and Christiansen I.K., 2020, HPV16 and HPV18 type-specific APOBEC3 and integration profiles in different diagnostic categories of cervical samples, Tumour Virus Research, 12: 200221. https://doi.org/10.1016/j.tvr.2021.200221 PMID: 34175494 PMCID: PMC8287217 Lou H., Boland J., Torres-Gonzalez E., Albanez A., Zhou W., Steinberg M., Diaw L., Mitchell J., Roberson D., Cullen M., Garland L., Bass S., Burk R.D., Yeager M., Wentzensen N., Schiffman M., Freites E.A., Gharzouzi E., Mirabello L., and Dean M., 2020, The D2 and D3 sublineages of human papilloma virus 16-positive cervical cancer in Guatemala differ in integration rate and age of diagnosis, Cancer Research, 80(17): 3803-3809. https://doi.org/10.1158/0008-5472.CAN-20-0029 PMID: 32631904 PMCID: PMC7501218 Ma B., Fang J., Wang Y., He H., Dai M., Lin W., Su W., and Zhang M., 2017, Isothermal method of a recombinase polymerase amplification assay for the detection of most common high-risk human papillomavirus type 16 and type 18 DNA, Clinical Laboratory, 63(1): 27-38. https://doi.org/10.7754/Clin.Lab.2016.160325 Mahantshetty U., Teni T., Naga P., Hotwani C., Umesh S., Kannan S., Hande V., Pawar S., Engineer R., Chopra S., Deodhar K., Maheshwari A., Gurram L., Gupta S., and Shrivastava S., 2017, Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy-a prospective observational study, Gynecologic Oncology, 148(2): 299-304. https://doi.org/10.1016/j.ygyno.2017.11.034 PMID: 29203175 Meng B., Quan L., Yang W., Lang J., Chen L., Dong R., and Tian G., 2019, Discovering HPV16 and HPV18 infection status and cancer gene variations in cervical cancer patient specimens by using Next-generation sequencing, Journal of Clinical Oncology, 37(15 Suppl): e13040. https://doi.org/10.1200/JCO.2019.37.15_SUPPL.E13040 Mirabello L., Yeager M., Cullen M., Boland J., Chen Z., Wentzensen N., Zhang X., Yu K., Yang Q., Mitchell J., Roberson D., Bass S., Xiao Y., Burdett L., Raine-Bennett T., Lorey T., Castle P.E., Burk R.D., and Schiffman M., 2016, HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women, Journal of the National Cancer Institute, 108(9): djw100. https://doi.org/10.1093/jnci/djw100 PMID: 27130930 PMCID: PMC5939630 Park J., Nickel K., Torres A., Lee D., Lambert P., and Kimple R., 2014, Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage, Radiotherapy and Oncology, 113(3): 337-344. https://doi.org/10.1016/j.radonc.2014.08.026 PMID: 25216575 PMCID: PMC4268372
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==